Science & Technology
Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43CA298492-01A1
Award Ceiling
$399K
Award Floor
$399K
Close Date
Aug 31, 2026
169 days leftTotal Funding
$399K
Expected Awards
1
Posted Date
Sep 10, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R43CA298492-01A1
Description
SBIR Phase Phase I award: "Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy" awarded to TIBA BIOTECH LLC in CAMBRIDGE, Massachusetts. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $399,300. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.